Center-Authored Papers

Filters: Author is Schultz, Kirk R  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
U
Woodard P, Carpenter PA, Davies SM, Gross TG, He W, Zhang M-J, Horn BN, Margolis DA, Perentesis JP, Sanders JE et al..  2011.  Unrelated donor bone marrow transplantation for myelodysplastic syndrome in children.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(5):723-8. Abstract
T
Bitan M, He W, Zhang M-J, Abdel-Azim H, Ayas MF, Bielorai B, Carpenter PA, Cairo MS, Diaz MA, Horan JT et al..  2014.  Transplantation for children with acute myeloid leukemia: a comparison of outcomes with reduced intensity and myeloablative regimens.. Blood. Abstract
S
Ayas M, Eapen M, Le-Rademacher J, Carreras J, Abdel-Azim H, Alter BP, Anderlini P, Battiwalla M, Bierings M, Buchbinder DK et al..  2015.  Second allogeneic hematopoietic cell transplantation for Patients with Fanconi anemia and Bone Marrow Failure.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
R
Gilman AL, Schultz KR, Goldman FD, Sale GE, Krailo MD, Chen Z, Langholz B, Jacobsohn DA, Chan K-W, Ryan RE et al..  2012.  Randomized trial of hydroxychloroquine for newly diagnosed chronic graft-versus-host disease in children: a Children's Oncology Group study.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(1):84-91. Abstract
P
Walker I, Panzarella T, Couban S, Couture F, Devins G, Elemary M, Gallagher G, Kerr H, Kuruvilla J, Lee SJ et al..  2015.  Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial.. The Lancet. Oncology. Abstract
Palmer JM, Lee SJ, Chai X, Storer BE, Flowers MED, Schultz KR, Inamoto Y, Cutler C, Pidala J, Arora M et al..  2012.  Poor Agreement between Clinician Response Ratings and Calculated Response Measures in Patients with Chronic Graft-versus-Host Disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(11):1649-55. Abstract
O
Shaw PJ, Kan F, Woo Ahn K, Spellman SR, Aljurf M, Ayas M, Burke M, Cairo MS, Chen AR, Davies SM et al..  2010.  Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors.. Blood. 116(19):4007-15. Abstract
N
Shulman HM, Cardona DM, Greenson JK, Hingorani S, Horn T, Huber E, Kreft A, Longerich T, Morton T, Myerson D et al..  2015.  NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 21(4):589-603. Abstract
Carpenter PA, Kitko CL, Elad S, Flowers MED, Gea-Banacloche JC, Halter JP, Hoodin F, Johnston L, Lawitschka A, McDonald GB et al..  2015.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Paczesny S, Hakim FT, Pidala J, Cooke KR, Lathrop J, Griffith LM, Hansen J, Jagasia M, Miklos D, Pavletic S et al..  2015.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 21(5):780-92. Abstract
M
Lee SJ, Wolff D, Kitko C, Koreth J, Inamoto Y, Jagasia M, Pidala J, Olivieri A, Martin PJ, Przepiorka D et al..  2015.  Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 21(6):984-99. Abstract
I
Arai S, Arora M, Wang T, Spellman SR, He W, Couriel DR, Urbano-Ispizua A, Cutler CS, Bacigalupo AA, Battiwalla M et al..  2015.  Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 21(2):266-74. Abstract
Pulsipher MA, Carlson C, Langholz B, Wall DA, Schultz KR, Bunin N, Kirsch I, Gastier-Foster JM, Borowitz M, Desmarais C et al..  2015.  IgH-V(D)J NGS-MRD measurement pre- and early post- allo-transplant defines very low and very high risk ALL patients.. Blood. Abstract
H
Battiwalla M, Wang T, Carreras J, Deeg HJ, Ayas M, Bajwa RPS, George B, Gupta V, Pasquini R, Schrezenmeier H et al..  2012.  HLA-matched sibling transplantation for severe aplastic anemia: impact of HLA DR15 antigen status on engraftment, graft-versus-host disease, and overall survival.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(9):1401-6. Abstract
Kariminia A, Holtan SG, Ivison S, Rozmus J, Hebert M-J, Martin PJ, Lee SJ, Wolff D, Subrt P, Abdossamadi S et al..  2016.  Heterogeneity of chronic graft-versus-host disease biomarkers: the only consistent association is with CXCL10 and CXCR3+ NK cells.. Blood. 127(24):3082-3091. Abstract
F
Couban S, Aljurf M, Lachance S, Walker I, Toze C, Rubinger M, Lipton JH, Lee SJ, Szer R, Doocey R et al..  2016.  Filgrastim-Stimulated Bone Marrow Compared with Filgrastim-Mobilized Peripheral Blood in Myeloablative Sibling Allografting for Patients with Hematologic Malignancies: A Randomized Canadian Blood and Marrow Transplant Group Study.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 22(8):1410-5. Abstract
C
Griffith LM, Pavletic SZ, Lee SJ, Martin PJ, Schultz KR, Vogelsang GB.  2008.  Chronic Graft-versus-Host Disease--implementation of the National Institutes of Health Consensus Criteria for Clinical Trials.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 14(4):379-84.
B
Cooke KR, Luznik L, Sarantopoulos S, Hakim FT, Jagasia M, Fowler DH, van den Brink MRM, Hansen JA, Parkman R, Miklos DB et al..  2016.  The Biology of Chronic Graft-Versus-Host Disease: a Task Force Report From the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-Versus-Host Disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
A
Pidala J, Wang T, Haagenson M, Spellman SR, Askar M, Battiwalla M, Baxter-Lowe LA, Bitan M, Fernandez-Viña M, Gandhi M et al..  2013.  Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality.. Blood. Abstract